1. Essential Oils and Their Main Chemical Components: The Past 20 Years of Preclinical Studies in Melanoma
    Marta Di Martile et al, 2020, Cancers CrossRef
  2. Indoleamine 2, 3-Dioxygenase: A Professional Immunomodulator and Its Potential Functions in Immune Related Diseases
    Fahimeh Heidari et al, 2020, International Reviews of Immunology CrossRef

  3. Development and Validation of an Immune-Related Gene Pair Signature in Skin Cutaneous Melanoma


    Ran Xie et al, 2020, CCID CrossRef
  4. Comprehensive Review on the Clinical Relevance of Long Non-Coding RNAs in Cutaneous Melanoma
    Vincenzo De Falco et al, 2021, IJMS CrossRef
  5. miRNA and mRNA expression profiling reveals potential biomarkers for metastatic cutaneous melanoma
    Jun Wang et al, 2021, Expert Review of Anticancer Therapy CrossRef
  6. Cancer Management during COVID-19 Pandemic: Is Immune Checkpoint Inhibitors-Based Immunotherapy Harmful or Beneficial?
    Silvia Vivarelli et al, 2020, Cancers CrossRef
  7. Gene signatures of 6-methyladenine regulators in women with lung adenocarcinoma and development of a risk scoring system: a retrospective study using the cancer genome atlas database
    Chundi Gao et al, 2021, Aging CrossRef
  8. Advances in Targeting Cutaneous Melanoma
    Dimitri Kasakovski et al, 2021, Cancers CrossRef
  9. The Role of Senescent Cells in Acquired Drug Resistance and Secondary Cancer in BRAFi-Treated Melanoma
    Elizabeth L. Thompson et al, 2021, Cancers CrossRef
  10. Treatment‐resistant bullous pemphigoid developing during therapy with immune checkpoint inhibitors
    E. Povilaityte et al, 2021, J Eur Acad Dermatol Venereol CrossRef
  11. null
    Karine Cohen Solal et al, 2021 CrossRef
  12. Immunotherapy in Acral and Mucosal Melanoma: Current Status and Future Directions
    Lili Mao et al, 2021, Front. Immunol. CrossRef
  13. Myositis/Myasthenia after Pembrolizumab in a Bladder Cancer Patient with an Autoimmunity-Associated HLA: Immune–Biological Evaluation and Case Report
    Cirino Botta et al, 2021, IJMS CrossRef
  14. Current Trends of Immunotherapy in the Treatment of Cutaneous Melanoma: A Review
    Piyu Parth Naik, 2021, Dermatol Ther (Heidelb) CrossRef
  15. Epigenetic Regulation in Melanoma: Facts and Hopes
    Emilio Francesco Giunta et al, 2021, Cells CrossRef
  16. Identification of subtypes correlated with tumor immunity and immunotherapy in cutaneous melanoma
    Qian Liu et al, 2021, Computational and Structural Biotechnology Journal CrossRef
  17. Dermoscopic Criteria, Histopathological Correlates and Genetic Findings of Thin Melanoma on Non-Volar Skin
    Cesare Massone et al, 2021, Genes CrossRef
  18. Identification of Immune Cell Infiltration Landscape and Their Prognostic Significance in Uveal Melanoma
    Han Zhao et al, 2021, Front. Cell Dev. Biol. CrossRef
  19. PARP Inhibitors in Melanoma—An Expanding Therapeutic Option?
    Wei Yen Chan et al, 2021, Cancers CrossRef
  20. Demographics, Pattern of Care, and Outcome Analysis of Malignant Melanomas - Experience From a Tertiary Cancer Centre in India
    Jyoti Bajpai et al, 2021, Front. Oncol. CrossRef
  21. Advances in the discovery and development of melanoma drug therapies
    Monica Chanda et al, 2021, Expert Opinion on Drug Discovery CrossRef
  22. Selective therapeutic benefit of X-rays and inhibitors of EGFR, PI3K/mTOR, and Bcl-2 in breast, lung, and cervical cancer cells
    Mogammad Baaghith Hamid et al, 2021, European Journal of Pharmacology CrossRef
  23. Ferroptosis-Related Gene Signature Predicts the Prognosis of Skin Cutaneous Melanoma and Response to Immunotherapy
    Ziqian Xu et al, 2021, Front. Genet. CrossRef
  24. NEDD4 E3 ubiquitin protein ligase serves an important role in cutaneous melanoma occurrence and development
    Fang Cheng et al, 2021, Exp Ther Med CrossRef
  25. Landscape and Clinical Significance of Immune Checkpoint in Cutaneous Melanoma
    Rui Mao et al, 2021, Front. Immunol. CrossRef
  26. Role of Biomarkers in the Integrated Management of Melanoma
    Piyu Parth Naik et al, 2021, Disease Markers CrossRef
  27. Companion Animal Model in Translational Oncology; Feline Oral Squamous Cell Carcinoma and Canine Oral Melanoma
    Antonio Giuliano, 2021, Biology CrossRef
  28. Synergistic Action of Immunotherapy and Nanotherapy against Cancer Patients Infected with SARS-CoV-2 and the Use of Artificial Intelligence
    Tanvi Gupta et al, 2022, Cancers CrossRef
  29. Biomarkers Associated with Immune-Related Adverse Events under Checkpoint Inhibitors in Metastatic Melanoma
    Marcus Wölffer et al, 2022, Cancers CrossRef
  30. Immunotherapy in skin cancers - A narrative review
    V. T. Anjali et al, 2022, JSSTD CrossRef
  31. In Vitro and In Ovo Assessment of Betulinic Acid Antimelanoma Effect
    Dorina Coricovac et al, 2020, Timisoara Med CrossRef
  32. Melanoma therapeutics: a literature review
    Pavan Kumar Dhanyamraju et al, 2022, J Biomed Res CrossRef
  33. The PIK3CA H1047R Mutation Confers Resistance to BRAF and MEK Inhibitors in A375 Melanoma Cells through the Cross-Activation of MAPK and PI3K–Akt Pathways
    Saverio Candido et al, 2022, Pharmaceutics CrossRef
  34. Identification and validation of a ferroptosis‐related gene signature for predicting survival in skin cutaneous melanoma
    Shuai Ping et al, 2022, Cancer Medicine CrossRef
  35. Novel Therapeutic Approaches with DNA Damage Response Inhibitors for Melanoma Treatment
    Luisa Maresca et al, 2022, Cells CrossRef
  36. IFN-γ and TNF Induce Senescence and a Distinct Senescence-Associated Secretory Phenotype in Melanoma
    Lorenzo Homann et al, 2022, Cells CrossRef
  37. The Overexpression of SLC25A13 Predicts Poor Prognosis and Is Correlated with Immune Cell Infiltration in Patients with Skin Cutaneous Melanoma
    Yue lv et al, 2022, Disease Markers CrossRef
  38. USP35 is a Potential Immunosuppressive Factor in Skin Cutaneous Melanoma
    Qian Zhang et al, 2022, JIR CrossRef
  39. Promising prognostic value of Transglutaminase type 2 and its correlation with tumor-infiltrating immune cells in skin cutaneous melanoma
    Silvia Muccioli et al, 2022, Cell Death Discov. CrossRef
  40. Ruthenium and iridium complexes bearing porphyrin moieties: PDT efficacy against resistant melanoma cells
    Nuno M.M. Moura et al, 2022, Dyes and Pigments CrossRef
  41. A Novel Necroptosis-Related Gene Signature in Skin Cutaneous Melanoma Prognosis and Tumor Microenvironment
    Binyu Song et al, 2022, Front. Genet. CrossRef
  42. A novel risk model based on cuproptosis-related lncRNAs predicted prognosis and indicated immune microenvironment landscape of patients with cutaneous melanoma
    Yi Zhou et al, 2022, Front. Genet. CrossRef
  43. Exploration and validation of metastasis-associated genes for skin cutaneous melanoma
    Hong Luan et al, 2022, Sci Rep CrossRef
  44. Advanced Acral Melanoma Therapies: Current Status and Future Directions
    Yiqun Zhang et al, 2022, Curr. Treat. Options in Oncol. CrossRef
  45. HLA-DRB1: A new potential prognostic factor and therapeutic target of cutaneous melanoma and an indicator of tumor microenvironment remodeling
    Huiling Deng et al, 2022, PLoS ONE CrossRef
  46. A Necroptosis-Related Gene Signature to Predict the Prognosis of Skin Cutaneous Melanoma
    Yihui Xie et al, 2022, Disease Markers CrossRef
  47. PGAM5: A necroptosis gene associated with poor tumor prognosis that promotes cutaneous melanoma progression
    Jianzhong Peng et al, 2022, Front. Oncol. CrossRef
  48. In vitro anti-melanoma activity of imiquimod in ultradeformable nanovesicles
    Ayelen Tatiana Caimi et al, 2022, Drug Development and Industrial Pharmacy CrossRef
  49. Prognostic Value of Lymphocyte-to-Monocyte Ratio (LMR) in Cancer Patients Undergoing Immune Checkpoint Inhibitors
    Luying Wan et al, 2022, Disease Markers CrossRef
  50. Genomics and Epigenomics in the Molecular Biology of Melanoma—A Prerequisite for Biomarkers Studies
    Daniela Luminita Zob et al, 2022, IJMS CrossRef
  51. A new ferroptosis-related genetic mutation risk model predicts the prognosis of skin cutaneous melanoma
    Jia He et al, 2023, Front. Genet. CrossRef
  52. 1,4-dihydroxy quininib modulates the secretome of uveal melanoma tumour explants and a marker of oxidative phosphorylation in a metastatic xenograft model
    Kayleigh Slater et al, 2023, Front. Med. CrossRef
  53. Peptide Vaccines in Melanoma: Chemical Approaches towards Improved Immunotherapeutic Efficacy
    Beáta Biri-Kovács et al, 2023, Pharmaceutics CrossRef
  54. Cytotoxic and Antioxidant Activity of Hypericum perforatum L. Extracts against Human Melanoma Cells from Different Stages of Cancer Progression, Cultured under Normoxia and Hypoxia
    Aleksandra Brankiewicz et al, 2023, Molecules CrossRef